In accordance with the 'Drug Approval Change Order' (Drug Safety Evaluation Division-No. 6717, effective date 2016. 12. 06), the efficacy and usage precautions of Repoxin Tablet have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.